SYGNIS AG Strengthens Management Team with Appointment of Dr. Heikki Lanckriet
Appointment strengthens management team and is effective from 5 August 2016
Madrid, Spain and Heidelberg, Germany, – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the appointment of Heikki Lanckriet, PhD, currently Chief Executive Officer (CEO) of Expedeon Holdings Ltd., as co-CEO and Chief Scientific Officer (CSO). The CSO role is a newly created position at SYGNIS. Dr. Lanckriet’s appointment became effective on August 5, 2016. He will alsobecome a member of the Management Board of SYGNIS, along with Pilar de la Huerta, who will serve as co-CEO and Chief Financial Officer (CFO) of the combined organization. Dr. Cristina Garmendia Mendizábal, Chairwoman of SYGNIS’s Supervisory Board, said: “We welcome Heikki to SYGNIS. With his track record in sales, marketing and operations and Pilar’s experience in the international finance, these two executives have skill sets that are highly complementary. Their joint leadership will serve the company well as the combined organiz

